New Onset Neurological Symptoms in Triple-Negative Breast Cancer Patient; Not Always Due to Metastasis
DOI:
https://doi.org/10.51253/pafmj.v75iSUPPL-4.5976Keywords:
Central nervous system, metastasis, neurological symptoms, triple-negative breast cancer.Abstract
The prognosis after central nervous system relapse in a triple negative breast cancer is grim. However, brain insult in a triple negative breast cancer is not always due to metastasis and other possibilities should be kept in mind too. We report a case of a young female, who had a local relapse of triple negative breast cancer and developed new onset neurological symptoms causing suspicion of CNS metastasis; however, the cause of neurological presentation was pre-existing comorbidities.
Downloads
References
- Witzel I, Oliveira-Ferrer L, Pantel K, Müller V, Wikman H. Breast cancer brain metastases: biology and new clinical perspectives. Breast Cancer Res. 2016 Dec 1; 18(1): 8.
- Wiens AL, Martin SE, Bertsch EC, Vance GH, Stohler RA, Cheng L, et al. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma. Arch Pathol Lab Med. 2014 Feb; 138(2): 175-81.
- Soni A, Ren Z, Hameed O, Chanda D, Morgan CJ, Siegal GP, et al. Breast cancer subtypes predispose the site of distant metastases. Am J Clin Pathol. 2015 Apr 1; 143(4): 471-8.
- Martin AM, Cagney DN, Catalano PJ, Warren LE, Bellon JR, Punglia RS, et al. Brain metastases in newly diagnosed breast cancer: a population-based study. JAMA Oncol. 2017 Aug 1; 3(8): 1069-77.
- Lin NU, Gaspar LE, Soffietti R. Breast cancer in the central nervous system: multidisciplinary considerations and management. Am Soc Clin Oncol Educ Book. 2017 Jan 1; 37,pp: 45-56.
- Kozak MM, Jacobson CE, von Eyben R, Walck E, Pollom EL, Telli M, et al. Patterns of distant failure by intrinsic breast cancer subtype in premenopausal women treated with neoadjuvant chemotherapy. Clin breast cancer. 2018 Oct 1; 18(5): e1077-85.
- Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. JNCI: J Natl Cancer Inst. 2003 Oct 1; 95(19): 1482-5.
- Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, et al. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin cancer Res. 2005 Jul 15; 11(14): 5175-80.
- Li R, Zhang K, Siegal GP, Wei S. Clinicopathological factors associated with survival in patients with breast cancer brain metastasis. Hum Pathol. 2017 Jun 1; 64: 53-60.
- Eichler AF, Kuter I, Ryan P, Schapira L, Younger J, Henson JW. Survival in patients with brain metastases from breast cancer: the importance of HER‐2 status. Cancer: Interdiscip Int J Am Cancer Soc. 2008 Jun 1; 112(11): 2359-67.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Jhanzeb Iftikhar, Muhammad Abubakar Sarwar, Syed Abdul Mannan Hamdani, Musa Azhar, Shafquat Ali Khan, Neelam Siddiqui
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
